Ensure funds for treatment of kids with rare diseases: Delhi HC directs Centre
The bench of Justice Rekha Palli said the court is of the view that the process is to be started from major hospitals across the country, such as AIIMS.
New Delhi: The Delhi High Court on Tuesday directed the Centre to ensure funds to cover the expenses towards the treatment of children suffering from rare diseases, saying the amount to be spent on such treatments and medicines can be adjusted from various funds, including the National Disability Fund.
The bench of Justice Rekha Palli said the court is of the view that the process is to be started from major hospitals across the country, such as AIIMS.
Also Read: HC raps Center over non-utilization of rare diseases fund
The court was hearing a batch of pleas pertaining to children suffering from rare diseases like Duchenne Muscular Dystrophy (DMD) and Hunter's syndrome, seeking direction to the Centre to provide them uninterrupted and free of cost treatment as the therapy is very expensive.
Hunter syndrome is a rare, inherited disorder in which the body does not properly digest (break down) sugar molecules, while Duchenne Muscular Dystrophy (DMD) is also an inherited disorder of progressive muscular weakness.
Senior advocate Siddharth Luthra, appearing on behalf of the petitioner, submitted that various public sector undertakings are contributing an amount of Rs 1,200 crore annually towards Corporate Social Responsibility (CSR).
The court said that the Centre can impress these PSUs to utilise these funds to online crowdfunding portals created for the treatment of children with rare diseases.
In September, the court had asked the Central government to take steps for transferring Rs 63 crore from the crowdfunding account lying with the Kerala High Court to that of the rare diseases account.
Today, the court said that it will be open for the Centre to pursue the application before the Kerala High Court for transfer of this fund.
Earlier on December 8, the court had pulled up the Centre for not utilising the funds collected to provide assistance for the treatment of children suffering from rare diseases, saying it will not permit these kids to "die despite funds being available".
Also Read: Former Religare CEO arrested for siphoning off Rs 2397 crore fund
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.